600
Participants
Start Date
November 1, 2017
Primary Completion Date
December 31, 2025
Study Completion Date
October 31, 2030
Lpv/r+3TC
It is a simplified therapy regimen study of lopinavir and ritonavir combined with lamivudine for HIV-1 infected patients in the real world of China.
RECRUITING
Guangzhou 8th People's Hospital, Guangzhou
Guiyang Public Health Clinical Center
UNKNOWN
The Third People's Hospital of Kunming
UNKNOWN
The Second People's Hospital of Nanjing
UNKNOWN
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
OTHER
The Third People's Hospital of Guilin
UNKNOWN
Guangxi Longtan hospital
UNKNOWN
The Fourth People's Hospital of Nanning
OTHER
LiuZhou People's Hospital
OTHER
Tianjin Second People's Hospital
OTHER
The Sixth People's Hospital of Shenyang
OTHER
The Sixth People's Hospital of Henan
UNKNOWN
The Sixth People's Hospital of Xinjiang
UNKNOWN
The Eighth People's Hospital of Xi'an
UNKNOWN
Guangzhou 8th People's Hospital
OTHER